JEFFREY S. ARONIN

Profile

First Name

: JEFFREY

Middle Name

: S.

Last Name

: ARONIN

Related Companies
Titles
Company Name
Related People
DIRECTOR
PARAGON BIOSCIENCES QLARITY CAPITAL, INC.
ANTONIO J. GRACIAS, PATRICK J. MORRIS, DARIEN PARHAD
DIRECTOR
CASTLE CREEK PHARMACEUTICAL HOLDINGS, INC.
JEFFREY ARONIN, DAVID BRILL, MATTHEW CRABTREE, TIMOTHY CUNNIFF, TIMOTHY M. CUNNIFF, MICHAEL DERBY, MATTHEW GANTZ, MATTHEW J. GANTZ, BABAR GHIAS, ANTONIO GRACIAS, ANTONIO J. GRACIAS, MARK GRAF, GREGORY MACMICHAEL, W. BRADFORD MIDDLEKAUFF, PATRICK MORRIS, PATRICK J. MORRIS, DARIEN PARHAD, MARY SPELLMAN, JUDE SULLIVAN, GREGORY WUJEK
EXECUTIVE OFFICER, DIRECTOR
EVOZYNE, LLC
MIKE GAMSON, ANTONIO GRACIAS, ALEINA LEE, PATRICK J MORRIS, PATRICK J. MORRIS, DARIEN PARHAD, ARJUN RALLAPALLI, RAMA RANGANATHAN, MATTHEW RIZZO, JUDE M. SULLIVAN, ARIS THEOLOGIS
DIRECTOR
CIRC BIOSCIENCES, INC.
JEFFREY ARONIN, SAI CHAVALA, TIMOTHY CUNNIFF, TIMOTHY M. CUNNIFF, ANTONIO GRACIAS, ANTONIO J. GRACIAS, PATRICK MORRIS, PATRICK J MORRIS, DARIEN PARHAD
EXECUTIVE OFFICER, DIRECTOR
EVOZYNE, INC.
MIKE GAMSON, ANTONIO GRACIAS, ALEINA LEE, PATRICK J MORRIS, PATRICK J. MORRIS, DARIEN PARHAD, ARJUN RALLAPALLI, RAMA RANGANATHAN, MATTHEW RIZZO, JUDE M. SULLIVAN, ARIS THEOLOGIS
DIRECTOR
CASTLE CREEK BIOSCIENCES, INC.
JEFFREY ARONIN, DAVID BRILL, MATTHEW CRABTREE, TIMOTHY CUNNIFF, TIMOTHY M. CUNNIFF, MICHAEL DERBY, MATTHEW GANTZ, MATTHEW J. GANTZ, BABAR GHIAS, ANTONIO GRACIAS, ANTONIO J. GRACIAS, MARK GRAF, GREGORY MACMICHAEL, W. BRADFORD MIDDLEKAUFF, PATRICK MORRIS, PATRICK J. MORRIS, DARIEN PARHAD, MARY SPELLMAN, JUDE SULLIVAN, GREGORY WUJEK
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-04-15 
2023-09-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-09-14 
2022-05-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-04-19 
2022-02-03
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2022-01-18 
2021-07-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-06-28 
2021-04-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-09 
2020-12-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-23 
2020-05-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-27 
2020-01-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-09 
2019-11-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-25